Skip to main content
. 2017 Jan 10;96(1):e5275. doi: 10.1097/MD.0000000000005275

Figure 2.

Figure 2

CD223-positive CD8+ T-lymphocyte was analyzed in patients with different HBV DNA and serum alanine aminotransferase (ALT) levels. Based on serum HBV DNA and ALT levels, 4 subgroups of patients were identified. Group I, high ALT and low DNA (n = 14); Group II, high ALT and high DNA (n = 38); Group III, low ALT and low DNA (n = 25); Group IV, low ALT and high DNA (n = 13). The frequency of CD223 expression in CD8+ lymphocytes was 41.79 ± 16.03% (Group I), 41.98 ± 18.63% (Group II), 38.99 ± 15.44% (Group III), and 34.09 ± 10.92% (Group IV). The difference among the 4 groups and the normal controls (HCs) was significant (∗P < 0.05).